Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124998952 | 12499895 | 2 | F | 20160321 | 20160726 | 20160627 | 20160728 | EXP | GB-009507513-1606GBR010708 | MERCK | 66.00 | YR | M | Y | 0.00000 | 20160728 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124998952 | 12499895 | 1 | PS | APREPITANT. | APREPITANT | 1 | Unknown | UNK | U | U | 21549 | CAPSULE | |||||||
| 124998952 | 12499895 | 2 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 675 MG, UNK | U | U | 0 | 675 | MG | ||||||
| 124998952 | 12499895 | 3 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | 156 MG, UNK | U | U | 0 | 156 | MG | ||||||
| 124998952 | 12499895 | 4 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNK | U | U | 0 | 6 | MG | ||||||
| 124998952 | 12499895 | 5 | SS | PEMETREXED DISODIUM | PEMETREXED DISODIUM | 1 | Unknown | 1050 MG, UNK | U | U | 0 | ||||||||
| 124998952 | 12499895 | 6 | SS | DENOSUMAB | DENOSUMAB | 1 | Unknown | 120 MG, UNK | U | U | 0 | 120 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124998952 | 12499895 | 1 | Product used for unknown indication |
| 124998952 | 12499895 | 2 | Product used for unknown indication |
| 124998952 | 12499895 | 3 | Product used for unknown indication |
| 124998952 | 12499895 | 4 | Product used for unknown indication |
| 124998952 | 12499895 | 5 | Product used for unknown indication |
| 124998952 | 12499895 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124998952 | 12499895 | HO |
| 124998952 | 12499895 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124998952 | 12499895 | Alopecia | |
| 124998952 | 12499895 | Contusion | |
| 124998952 | 12499895 | Cough | |
| 124998952 | 12499895 | Decreased appetite | |
| 124998952 | 12499895 | Dehydration | |
| 124998952 | 12499895 | Dizziness | |
| 124998952 | 12499895 | Dysgeusia | |
| 124998952 | 12499895 | Dyspnoea | |
| 124998952 | 12499895 | Epistaxis | |
| 124998952 | 12499895 | Fall | |
| 124998952 | 12499895 | Fatigue | |
| 124998952 | 12499895 | Flushing | |
| 124998952 | 12499895 | Headache | |
| 124998952 | 12499895 | Joint swelling | |
| 124998952 | 12499895 | Malaise | |
| 124998952 | 12499895 | Melaena | |
| 124998952 | 12499895 | Neuropathy peripheral | |
| 124998952 | 12499895 | Ocular hyperaemia | |
| 124998952 | 12499895 | Paraesthesia | |
| 124998952 | 12499895 | Rhinorrhoea | |
| 124998952 | 12499895 | Somnolence | |
| 124998952 | 12499895 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124998952 | 12499895 | 2 | 20160321 | 0 | ||
| 124998952 | 12499895 | 3 | 20160321 | 0 | ||
| 124998952 | 12499895 | 4 | 20160322 | 0 | ||
| 124998952 | 12499895 | 5 | 20160321 | 0 |